Information Provided By: 
Fly News Breaks for February 27, 2019
CNMD
Feb 27, 2019 | 09:39 EDT
Needham analyst Mike Matson raised his price target on on Conmed to $87 and kept his Buy rating, updating his model to include the increased revenue from its acquisition of Buffalo Filter. The analyst contends that his estimates for Buffalo Filter could also prove conservative in light of its limited presence outside the U.S. market, given Conmed's position as an "established international sales organization".
News For CNMD From the Last 2 Days
There are no results for your query CNMD
